Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · IEX Real-Time Price · USD
4.750
+0.130 (2.81%)
May 16, 2024, 4:00 PM EDT - Market closed
Sagimet Biosciences Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$38.80
Upside
+716.84%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $27 → $23 | Strong Buy | Maintains | $27 → $23 | +384.21% | May 16, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +573.68% | May 16, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +573.68% | May 2, 2024 |
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $37 → $27 | Strong Buy | Maintains | $37 → $27 | +468.42% | Mar 26, 2024 |
Leerink Partners | Leerink Partners | Buy Initiates $26 | Buy | Initiates | $26 | +447.37% | Mar 25, 2024 |
JMP Securities | JMP Securities | Buy Maintains $47 → $46 | Buy | Maintains | $47 → $46 | +868.42% | Feb 7, 2024 |
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $30 → $37 | Strong Buy | Maintains | $30 → $37 | +678.95% | Jan 23, 2024 |
JMP Securities | JMP Securities | Buy Maintains $31 → $47 | Buy | Maintains | $31 → $47 | +889.47% | Jan 23, 2024 |
JMP Securities | JMP Securities | Buy Maintains $31 → $47 | Buy | Maintains | $31 → $47 | +889.47% | Jan 22, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $31 | Buy | Reiterates | $31 | +552.63% | Dec 5, 2023 |
TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 8, 2023 |
Piper Sandler | Piper Sandler | Buy Initiates $67 | Buy | Initiates | $67 | +1,310.53% | Aug 8, 2023 |
JMP Securities | JMP Securities | Buy Initiates $30 | Buy | Initiates | $30 | +531.58% | Aug 8, 2023 |
Goldman Sachs | Goldman Sachs | Strong Buy Initiates $33 | Strong Buy | Initiates | $33 | +594.74% | Aug 8, 2023 |